Search Results
1 - 12 of 83 matches
Sort by:
Role of Inflammation in Coronary Heart Disease: Why Does it Matter
Presenter:
Deepak Bhatt
October 29, 2024
Inflammation- Current and Emerging Therapeutic Landscape
Presenter:
Deepak Bhatt
October 29, 2024
Finding the Sweet Spot: Balancing Reducing Ischemic Risk and Reducing Bleeding Risk with Antiplatelet Therapy
Presenter:
Deepak Bhatt
November 5, 2021
Antiplatelet Therapy for Patients with Diabetes Undergoing PCI
Presenter:
Deepak Bhatt
November 5, 2021
Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction
Presenter:
Deepak L. Bhatt
May 17, 2021
EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
Presenter:
Deepak L. Bhatt
March 30, 2020
THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes
Presenter:
Deepak Bhatt
September 1, 2019
The Evolution in PCI Pharmacology Over the Past 25 Years
Presenter:
Deepak L. Bhatt
April 12, 2019
First Randomized Human Experience with a Ticagrelor Reversal Agent
Presenter:
Deepak L. Bhatt
March 18, 2019
REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
Presenter:
Deepak L Bhatt
November 16, 2018
Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!
Presenter:
Anthony H. Gershlick, Deepak L. Bhatt, Pieter C. Smits
September 24, 2018